Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac

Jesús A. Junco, Marta Ayala, Franklin Fuentes et al.|Frontiers in Oncology|2019

Cited by 19